Determination of sensitivity to BET and HDAC inhibitors in lung cancer cell lines

被引:0
|
作者
Verdura, Sara
Torres-Diz, Manuel
Sanchez-Cespedes, Montserrat
机构
关键词
D O I
10.1158/1538-7445.AM2017-5073
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5073
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Histone deacetylase (HDAC) encoding gene expression in pancreatic cancer cell lines and cell sensitivity to HDAC inhibitors
    Ouaissi, M.
    Cabral, S.
    Tavares, J.
    da Silva, A. Cordeiro
    Mathieu-Daude, F.
    Mas, E.
    Bernard, J. P.
    Sastre, B.
    Lombardo, D.
    Ouaissi, Ali
    CANCER BIOLOGY & THERAPY, 2008, 7 (04) : 523 - 531
  • [2] Combination of HDAC and topoisomerase inhibitors in small cell lung cancer
    Gray, Jhanelle
    Cubitt, Christopher L.
    Zhang, Shumin
    Chiappori, Alberto
    CANCER BIOLOGY & THERAPY, 2012, 13 (08) : 614 - 622
  • [3] Metabolic targeting, HDAC inhibitors, and non small cell lung cancer?
    Gray, S. G.
    O'Byrne, K. J.
    Ahmad, S.
    LUNG CANCER, 2009, 63 : S1 - S1
  • [4] Gene alteration profile and correlation to sensitivity to small molecule inhibitors in lung cancer cell lines
    Blanco, R.
    Tang, M.
    Angulo, B.
    Sanchez-Cespedes, M.
    EJC SUPPLEMENTS, 2008, 6 (09): : 31 - 31
  • [5] Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer
    He, Shipeng
    Dong, Guoqiang
    Li, Yu
    Wu, Shanchao
    Wang, Wei
    Sheng, Chunquan
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (08) : 3028 - 3032
  • [6] DIFFERENCES IN SENSITIVITY OF ENDOMETRIAL CANCER CELL LINES TO SPECIFIC INHIBITORS
    Polymeros, K.
    Macip, S.
    Moss, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 1036 - 1036
  • [7] Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
    Lockwood, William W.
    Zejnullahu, Kreshnik
    Bradner, James E.
    Varmus, Harold
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (47) : 19408 - 19413
  • [8] HDAC inhibitors: a new radiosensitizer for non-small-cell lung cancer
    Zhu, Lucheng
    Wu, Kan
    Ma, Shenglin
    Zhang, Shirong
    TUMORI, 2015, 101 (03) : 257 - 262
  • [9] Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
    Sixto-Lopez, Yudibeth
    Antonio Gomez-Vidal, Jose
    de Pedro, Nuria
    Bello, Martiniano
    Cecilia Rosales-Hernandez, Martha
    Correa-Basurto, Jose
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [10] Circumvention of TKI resistance with HDAC inhibitors in lung cancer
    Yano, Seiji
    ANNALS OF ONCOLOGY, 2015, 26 : 19 - 19